A multicenter, prospective cohort study of Tongqiao Biyan granule in the prevention and treatment of asthma allergic rhinitis in children based on the real medical environment and the Chi

Phase 4

• Conditions: Children's asthma allergic rhinitis

• Registration Number: ITMCTR2200006864
• Lead Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) having a history of asthma with allergic rhinitis, (2) being 3-13 years old (< 14 years old) , (3) having entered the Chinese childhood asthma action plan and using leisurely breathing APP, being in the Green Zone of asthma, (4) the symptoms of rhinitis (nasal obstruction, nasal discharge, sneezing, nasal itching) appeared recently (nearly 1 week) , or the symptoms of rhinitis aggravated to moderate-severe recently (nearly 1 week) ; (5) voluntary participation in the study and informed consent signed by the legal guardian or with the child (=8 years old) .

Exclusion Criteria

(1) having diseases that need to be differentiated from AR, such as upper and lower respiratory tract infection, acute rhinosinusitis, etc. ;
(2) having risk factors of fatal asthma attack;
(3) being allergic to Tongqiao Biyan granule and its components.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Asthma symptom score;Total score of nasal symptoms;